Skip to main content
Top
Published in: Cough 1/2008

Open Access 01-12-2008 | Short report

The utility of the mannitol challenge in the assessment of chronic cough: a pilot study

Authors: Amisha Singapuri, Susan McKenna, Christopher E Brightling

Published in: Cough | Issue 1/2008

Login to get access

Abstract

There is a need for more objective outcome measures for chronic cough. In this pilot study we sought to investigate the utility of the mannitol challenge as a cough-provocation test in non-asthmatic chronic cough. We studied 16 healthy controls and 13 subjects with chronic cough. We assessed cough severity using a visual analogue score, capsaicin cough sensitivity, health status using the Leicester Cough Questionnaire and the dose of mannitol to cause 2 (C2) or 5 (C5) coughs. In all of the subjects with chronic cough and 6 of the controls we assessed the 1-week repeatability of the mannitol challenge. We found that in those subjects with chronic cough the geometric mean (logSEM) mannitol C2 and C5 was heightened compared to controls (C2: 4 (0.2) versus 16 (0.1); p = 0.04 and C5: 63 (0.1) versus 251 (0.1); p = 0.04). Cough visual analogue score, capsacin-induced cough sensitivity and health status were also altered in chronic cough compared to healthy controls, but in those subjects with chronic cough none of these outcomes was correlated with the mannitol C2 or C5. The repeatability of the mannitol challenge assessed by intraclass correlation was C2 = 0.53 and C5 = 0.59. A cut-off in the dose of mannitol of 62 mg/ml for C2 and 550 mg/ml for C5 had a sensitivity of 69 and 62% and specificity of 69 and 81% respectively to distinguish chronic coughers from healthy controls. In conclusion, the mannitol challenge my have potential as a novel cough challenge test and further work is required to extend our findings and to assess whether it has utility in different causes of chronic cough.
Appendix
Available only for authorised users
Literature
1.
go back to reference Morice AH, Fontana GA, Belvisis MG, Birring SS, Chung KF, Dicpinigaitis PV, Kastelik JA, McGarvey LP, Smith JA, Tatar M, et al: ERS guidelines on the assessment of cough. Eur Respir J. 2007, 29: 1256-1276. 10.1183/09031936.00101006.CrossRefPubMed Morice AH, Fontana GA, Belvisis MG, Birring SS, Chung KF, Dicpinigaitis PV, Kastelik JA, McGarvey LP, Smith JA, Tatar M, et al: ERS guidelines on the assessment of cough. Eur Respir J. 2007, 29: 1256-1276. 10.1183/09031936.00101006.CrossRefPubMed
2.
go back to reference Irwin RS: Assessing cough severity and efficacy of therapy in clinical research: ACCP evidence-based clinical practice guidelines. Chest. 2006, 129 (1): 232S-237S. 10.1378/chest.129.1_suppl.232S.CrossRefPubMed Irwin RS: Assessing cough severity and efficacy of therapy in clinical research: ACCP evidence-based clinical practice guidelines. Chest. 2006, 129 (1): 232S-237S. 10.1378/chest.129.1_suppl.232S.CrossRefPubMed
3.
go back to reference Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MD, Pavord ID: Development of a Symptom Specific Health Status Measure for Patients with Chronic Cough: Leicester Cough Questionnaire (LCQ). Thorax. 2003, 58 (4): 339-43. 10.1136/thorax.58.4.339.PubMedCentralCrossRefPubMed Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MD, Pavord ID: Development of a Symptom Specific Health Status Measure for Patients with Chronic Cough: Leicester Cough Questionnaire (LCQ). Thorax. 2003, 58 (4): 339-43. 10.1136/thorax.58.4.339.PubMedCentralCrossRefPubMed
4.
go back to reference Smith JA, Earis JE, Woodcock AA: Establishing a gold standard for manual cough conting: video versus digital audio recordings. Cough. 2006, 2: 6-10.1186/1745-9974-2-6.PubMedCentralCrossRefPubMed Smith JA, Earis JE, Woodcock AA: Establishing a gold standard for manual cough conting: video versus digital audio recordings. Cough. 2006, 2: 6-10.1186/1745-9974-2-6.PubMedCentralCrossRefPubMed
5.
go back to reference Birring SS, Fleming T, Matos S, Raj AA, Evans DH, Pavord ID: The Leicester cough monitor: preliminary validation of an automated cough detection system in chronic cough. Eur Respi J. 2008, 31 (5): 1013-8. 10.1183/09031936.00057407.CrossRef Birring SS, Fleming T, Matos S, Raj AA, Evans DH, Pavord ID: The Leicester cough monitor: preliminary validation of an automated cough detection system in chronic cough. Eur Respi J. 2008, 31 (5): 1013-8. 10.1183/09031936.00057407.CrossRef
6.
go back to reference Dicpinigaitis PV: Chronic cough due to asthma: ACCP evidence-based clinical practice guidelines. Chest. 2006, 129 (1): 75S-79S. 10.1378/chest.129.1_suppl.75S.CrossRefPubMed Dicpinigaitis PV: Chronic cough due to asthma: ACCP evidence-based clinical practice guidelines. Chest. 2006, 129 (1): 75S-79S. 10.1378/chest.129.1_suppl.75S.CrossRefPubMed
7.
go back to reference Anderson SD, Brannan J, Spring J, Spalding N, Rodwell LT, Chan K, Gonda I, Walsh A, Clark AR: A new method for bronchial-provocation testing in asthmatic subjects using a dry powder mannitol. Am J Respir Crit Care Med. 1997, 156: 758-65.CrossRefPubMed Anderson SD, Brannan J, Spring J, Spalding N, Rodwell LT, Chan K, Gonda I, Walsh A, Clark AR: A new method for bronchial-provocation testing in asthmatic subjects using a dry powder mannitol. Am J Respir Crit Care Med. 1997, 156: 758-65.CrossRefPubMed
8.
go back to reference Brannan JD, Anderson SD, Perry CP, Freed-Martens R, Lassig AR, Charlton B, Aridol study group: The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline. Respir Res. 2005, 6: 144-10.1186/1465-9921-6-144.PubMedCentralCrossRefPubMed Brannan JD, Anderson SD, Perry CP, Freed-Martens R, Lassig AR, Charlton B, Aridol study group: The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline. Respir Res. 2005, 6: 144-10.1186/1465-9921-6-144.PubMedCentralCrossRefPubMed
9.
go back to reference Braanan JD, Gulliksson M, Anderson SD, Chew N, Kumlin M: Evidence of mast cell activation and leukotriene release after mannitol inhalation. Eur Respir J. 2003, 22 (3): 491-6. 10.1183/09031936.03.00113403.CrossRef Braanan JD, Gulliksson M, Anderson SD, Chew N, Kumlin M: Evidence of mast cell activation and leukotriene release after mannitol inhalation. Eur Respir J. 2003, 22 (3): 491-6. 10.1183/09031936.03.00113403.CrossRef
10.
go back to reference Chausow AM, Banner AS: Comparison of the tussive effects of histamine and methacholine in humans. J Appl Physiol. 1983, 55 (2): 541-6.PubMed Chausow AM, Banner AS: Comparison of the tussive effects of histamine and methacholine in humans. J Appl Physiol. 1983, 55 (2): 541-6.PubMed
11.
go back to reference Koskela HO, Hyvarinen L, Brannan JD, Chan HK, Anderson SD: Coughing during mannitol challenge is associated with asthma. Chest. 2004, 125: 1985-1992. 10.1378/chest.125.6.1985.CrossRefPubMed Koskela HO, Hyvarinen L, Brannan JD, Chan HK, Anderson SD: Coughing during mannitol challenge is associated with asthma. Chest. 2004, 125: 1985-1992. 10.1378/chest.125.6.1985.CrossRefPubMed
12.
go back to reference Pratter MR, Brightling CE, Boulet LP, Irwin RS: An empiric approach to the management of cough: ACCP evidence-based clinical practice guidelines. Chest. 2006, 129 (1): 222S-231S. 10.1378/chest.129.1_suppl.222S.CrossRefPubMed Pratter MR, Brightling CE, Boulet LP, Irwin RS: An empiric approach to the management of cough: ACCP evidence-based clinical practice guidelines. Chest. 2006, 129 (1): 222S-231S. 10.1378/chest.129.1_suppl.222S.CrossRefPubMed
13.
go back to reference Brightling CE, Monterio W, Green RH, Parker D, Morgan MD, Wardlaw AJ, Pavord ID: Induced sputum and other outcome measures in chronic obstructive pulmonary disease: safety and repeatability. Respir Med. 2001, 95 (12): 999-1002. 10.1053/rmed.2001.1195.CrossRefPubMed Brightling CE, Monterio W, Green RH, Parker D, Morgan MD, Wardlaw AJ, Pavord ID: Induced sputum and other outcome measures in chronic obstructive pulmonary disease: safety and repeatability. Respir Med. 2001, 95 (12): 999-1002. 10.1053/rmed.2001.1195.CrossRefPubMed
14.
go back to reference Prudon B, Birring SS, Vara DD, Hall AP, Thompson JP, Pavord ID: Cough and glottic-stop reflex sensitivity in health and disease. Chest. 2005, 127: 550-557. 10.1378/chest.127.2.550.CrossRefPubMed Prudon B, Birring SS, Vara DD, Hall AP, Thompson JP, Pavord ID: Cough and glottic-stop reflex sensitivity in health and disease. Chest. 2005, 127: 550-557. 10.1378/chest.127.2.550.CrossRefPubMed
15.
go back to reference Brightling CE, Ward R, Wardlaw AJ, Pavord ID: Airway inflammation, airway responsiveness and cogh before and after inhaled budesonide in patients with eosinophilic bronchitis. Eur Respir J. 2000, 15 (4): 682-6. 10.1034/j.1399-3003.2000.15d10.x.CrossRefPubMed Brightling CE, Ward R, Wardlaw AJ, Pavord ID: Airway inflammation, airway responsiveness and cogh before and after inhaled budesonide in patients with eosinophilic bronchitis. Eur Respir J. 2000, 15 (4): 682-6. 10.1034/j.1399-3003.2000.15d10.x.CrossRefPubMed
16.
go back to reference Siddiqui S, Mistry V, Doe C, Roach K, Morgan A, Wardlaw A, Pavord I, Bradding P, Brightling C: Airway hyperresponsiveness is dissociated from airway structural remodelling. J Allergy Clin Immunol. 2008, 122 (2): 335-41. 10.1016/j.jaci.2008.05.020.PubMedCentralCrossRefPubMed Siddiqui S, Mistry V, Doe C, Roach K, Morgan A, Wardlaw A, Pavord I, Bradding P, Brightling C: Airway hyperresponsiveness is dissociated from airway structural remodelling. J Allergy Clin Immunol. 2008, 122 (2): 335-41. 10.1016/j.jaci.2008.05.020.PubMedCentralCrossRefPubMed
17.
go back to reference Siddiqui S, Hollins F, Saha S, Brightling CE: Inflammatory cell microlocalisation and airway dysfunction: cause and effect?. Eur Respir J. 2007, 30 (6): 1043-56. 10.1183/09031936.00162506.CrossRefPubMed Siddiqui S, Hollins F, Saha S, Brightling CE: Inflammatory cell microlocalisation and airway dysfunction: cause and effect?. Eur Respir J. 2007, 30 (6): 1043-56. 10.1183/09031936.00162506.CrossRefPubMed
Metadata
Title
The utility of the mannitol challenge in the assessment of chronic cough: a pilot study
Authors
Amisha Singapuri
Susan McKenna
Christopher E Brightling
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Cough / Issue 1/2008
Electronic ISSN: 1745-9974
DOI
https://doi.org/10.1186/1745-9974-4-10

Other articles of this Issue 1/2008

Cough 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine